NEW YORK STOCK EXCHANGE, INC. · ENOV
-0.62% · -$0.1100 · Vol Not reported
Pre-market · updated 04:00:35 ET
Enovis Corp

Enovis Corp

Health Care
$17.50
Card
Relationship Map

Follow $ENOV

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ENOV by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
ENOV
Enovis Corp
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ENOV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ENOV catalysts
About Enovis Corp
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed since
2008
Employees
8K
Country
US

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$17.61
Last session
Day high
$17.61
Last session
Day low
$17.61
Last session
Previous close
$17.61
52W high
$32.87
-46.76% from high
52W low
$17.50
0% of range
Market cap
$1B
EPS
$-19.2672
Beta
0.59
Shares out
57.7M
Avg volume
1.9M
VWAP
$17.61
Last session
Price history computed in-house
1W
-3.05%
1M
-12.41%
3M
-32.04%
1Y
-44.93%
YTD
-34.31%
SMA 50 $22.43 · below
SMA 200 $23.66 · below
52W position 0%

ENOV overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading ENOV Form 4 filings
Public disclosures

Congress activity in ENOV

No receipt-qualified filings found.

Federal contracts

ENOV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENOV in this window.
Lobbying spend

ENOV lobbying filings, year to date.

Registered lobbying filings matched to Enovis Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENOV in this window.
Loading news for ENOV
Analyst ratings
Sovereign unlock shows live analyst consensus for ENOV.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.